SCHEMBL13706282

SCHEMBL13706282

c1ccc(-c2ccc3sc4ccc(-c5cc6ccccc6cc5-c5ccccc5)cc4c3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.44
PTGS2 P35354 1/20 0.44
LIMK1 P53667 1/20 0.42
ROCK1 Q13464 1/20 0.40
F9 P00740 3/20 0.40
PIK3CA P42336 2/20 0.39
PI4KA P42356 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
GPR84 Q9NQS5 1/20 0.38
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
PIM1 P11309 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
TRIM58 Q8NG06 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13520281 0.93 GSTP1 (0.44) PIM3PTGS2ESR1ESR2GPR84
SCHEMBL13706288 0.89 CYP11B1 (0.44) PIM3PTGS2LIMK1GPR84HSD17B1
SCHEMBL13706287 0.87 MCL1 (0.44) PTGS2F9KDM4EMEN1ALDH1A1
SCHEMBL13706098 0.87 HSD17B1 (0.40) PIM3PTGS2F9GPR84HSD17B1
SCHEMBL13706155 0.85 ALOX5 (0.38) PIM3PTGS2LIMK1F9GPR84
SCHEMBL13706188 0.85 GPR3 (0.38) PIM3PTGS2LIMK1F9ESR1
SCHEMBL29828944 0.85 LIMK1 (0.51) PIM3LIMK1ROCK1F9PIK3CA
SCHEMBL14296006 0.85 LIMK1 (0.51) PIM3LIMK1ROCK1F9PIK3CA
SCHEMBL3156901 0.85 LIMK1 (0.51) PIM3LIMK1ROCK1F9PIK3CA
SCHEMBL13979459 0.83 F9 (0.44) PIM3PTGS2LIMK1F9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090230852-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-09-17 US disclosed
US-20090230852-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090230852-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OXER1, L1CAM, RPL41 PIM3 4029/4885PTGS2 4026/4885LIMK1 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.